견적문의

GOLETA, CALIF.--( / )--Transphorm, Inc. (OTCQX: TGAN)?a pioneer in and global supplier of high reliability, high performance gallium nitride (GaN) power conversion products?today announced the expansion of its design tools using digital signal processing technology from Microchip Technology. The TDTTP2500B066B-KIT is a 2.5 kW AC-to-DC bridgeless totem pole power factor correction (PFC) evaluation board. It pairs Transphorm’s SuperGaN® FETs with Microchip’s dsPIC33CK digital signal controller (DSC) board, which includes pre-programmed firmware that can be easily customized per end application requirements. Use of the new board enables faster development of Data Center and Broad Industrial power supplies.

New Device + New Feature = Increased Development Functionality

The TDTTP2500B066B-KIT is available off-the-shelf with a daughter card using Transphorm’s latest SuperGaN Gen IV device, the TP65H050G4BS?a 650 V SMD SuperGaN FET in a TO-263 (D2PAK) offering a typical on-resistance of 50 milliohms.

The new board also introduces an advanced feature to increase its usability: swappable daughter cards housing Transphorm’s GaN devices. As a result, design engineers can also evaluate the TP65H070LDG/LSG GaN devices with a 72 milliohm on-resistance through the use of a second optional daughter card?the TDHB-65H070L-DC?sold separately. This daughter card is a drop-in replacement for the 50 milliohm FET card.

As with the first SuperGaN/Microchip DSC evaluation board (the 4 kW TDTTP4000W066C-KIT), the 2.5 kW board is backed by access to Microchip’s worldwide technical support team for firmware development assistance.

“Our continued collaboration with Transphorm delivers innovative power electronics solutions for the growing GaN power conversion market,” said Joe Thomsen, vice president of Microchip’s MCU16 business unit. “Microchip is heavily invested in leading technological change through smart integrated solutions. The performance and flexibility of our digital signal processors are a perfect fit for the demanding requirements of GaN-based power conversion applications.”

Microchip’s dsPIC® DSCs are supported by a set of embedded design tools created to empower developers, even those with limited expertise. These tools provide intuitive graphic user interfaces for device initialization in Microchip’s free MPLAB® X Integrated Development Environment. The software tools are complemented by a full line of programmer, debugger and emulator accessories.

Technical Specifications

The DSC-integrated solution used in Transphorm’s TDTTP2500B066B-KIT features:

· 650 V 50 mΩ SuperGaN FET (TP65H050G4BS)

· Input voltage: 85 VACto 265 VAC, 47Hz to 63Hz

· Input current: 18 Arms; 1250 W at 115VAC, 2500 kW at 230 VAC

· Output voltage: 390 VDC± 5 VDC (programmable)

· Deadtime: programmable

· PWM frequency: 66kHz

· Power factor: > 0.99

The board is designed around Microchip’s dsPIC33CK digital power plug in module (PIM) to control the PFC powertrain, with the following pre-programmed PIM features:

· Microchip’s AEC-Q100-qualified dsPIC33CK256MP506 digital signal controller

· 100 MIPS for fast deterministic performance in time-critical control applications

· Dual Flash Panels - to enable live update of code while power supply is running

· High analog integration for reduced BOM costs and minimum system size

· PWMs with 250 ps resolution

Firmware updates for the dsPIC33CK PIM will be available for download from Microchip’s website.

“We’re ensuring our customers can easily leverage our GaN platform’s advantages by eliminating design challenges, simplifying development, and quickening go-to-market ramps. Integrating Microchip’s sophisticated DSC capabilities is crucial to that mission,” said Philip Zuk, SVP of Worldwide Technical Marketing and Business Development, Transphorm. “We now offer the most commonly required power stage where GaN offers its highest value proposition in two power levels with pre-programmed firmware and an interchangeable GaN device configuration.”

Availability

The TDTTP2500B066B-KIT is available through Digi-Key and Mouser.

Customers interested in evaluating Transphorm’s 70 milliohm FETs can order the TDHB-65H070L-DC daughter card here.

About Transphorm

Transphorm, Inc., a global leader in the GaN revolution, designs and manufactures high performance and high reliability GaN semiconductors for high voltage power conversion applications. Having one of the largest Power GaN IP portfolios of more than 1,000 owned or licensed patents, Transphorm produces the industry’s first JEDEC and AEC-Q101 qualified high voltage GaN semiconductor devices. The Company’s vertically integrated device business model allows for innovation at every development stage: design, fabrication, device, and application support. Transphorm’s innovations are moving power electronics beyond the limitations of silicon to achieve over 99% efficiency, 40% more power density and 20% lower system cost. Transphorm is headquartered in Goleta, California and has manufacturing operations in Goleta and Aizu, Japan. For more information, please visit Follow us on Twitter @transphormusa and WeChat @ Transphorm_GaN.

The SuperGaN mark is a registered trademark of Transphorm, Inc. All other trademarks are the property of their respective owners.

View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

NEW YORK--( / )--Medidata, a 장동성인오락실 Dassault Systemes company, and Boehringer Ingelheim 전생체험 today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The new agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata, Medidata’s 배팅길잡이 suite of innovative 토토와프로토이야기 patient-facing technologies focused on enhancing patient centricity and 장동성인오락실 이민정닮은꼴 diversity in decentralized clinical trials (DCTs).

The agreement adds to Boehringer Ingelheim’s focus on engaging patients in a meaningful way 장동성인오락실 조민서태왕사신기 by providing Medidata’s scalable patient-centered capabilities. This 먹튀나라 includes the 충북보드카페 Thepatient portal, a single-destination web-based platform, which provides access to electronic consent, electronic Clinical Outcome Assessment (eCOA), and myMedidata LIVE video investigator/patient visits.

“As industry leaders, Boehringer Ingelheim and Medidata have a responsibility to innovate for the benefit of patients,” said Anthony Costello, CEO Patient Cloud at Medidata. “Boehringer Ingelheim’s global reach 오마이갓신혼부부 across therapeutic areas is a perfect match for the scalable capabilities of myMedidata and the rest of 장동성인오락실 먹튀공원 the Medidata Clinical Cloud platform. Together, we will be able to quickly improve access 장동성인오락실 알파TV and diversity of participation in a wide range of clinical programs.”

The Medidata Decentralized Clinical Trials Program - the industry’s only scalable, end-to-end offering - is helping to revolutionize 킹스포커 how individuals provide data, how drugs are shipped to 장동성인오락실 StudioR3 patients, and bj빙빙 how clinical trial data are managed and monitored. Most importantly, these remote technologies create opportunities to improve patient access, inclusion, and engagement across geographies, and improve patient diversity in clinical trials.

Boehringer Ingelheim has built 장동성인오락실 i컵브라 on Medidata technologies, including Rave 장동성인오락실 이서이 EDC (electronic 장동성인오락실 data capture), Coder, TSDV (targeted source data verification), and Safety Gateway. Boehringer Ingelheim is 지성 also exploring Medidata AI Intelligent Trials to provide advanced analytics to improve the speed, success, and quality of clinical trials, and 동두천동전방 Boehringerbenefitting from Medidata Rave Imaging technology via services contracted with the company’s imaging suppliers.

Medidata is a wholly 가슴이쁜연예인 owned subsidiary of 화성인i컵 Dassault Systemes, which with its 3DEXPERIENCE platform is positioned to lead the digital 허윤미 transformation 장동성인오락실 화성인바이러스v걸오시은 of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About 지명 장동성인오락실 지명 올림픽공원역홀덤딜러 About 김아중f컵 장동성인오락실 김아중f컵

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize 장동성인오락실 베이글비비 outcomes. More than one million registered users across 2,000+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systemes company (Euronext Paris: FR0014003TT8, DSY.PA), is 장동성인오락실 Jellytoe headquartered in New York City and has offices around the 한송이가슴성형 world to meet the needs of its customers. Discover more e컵녀 at and follow 지아월드 us @Medidata.

About 장동성인오락실 한송이노출 Dassault 다빈 Systemes

Dassault Systemes, the 3DEXPERIENCE Company, is a catalyst for human progress. We 이승연과100인의여자얼굴작아... provide business and people with collaborative 3D virtual 뽕찌찌 environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, 장동성인오락실 citizens, and consumers. Dassault Systemes brings value to more 누나넷야사 than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, 역삼역홀덤동호회 3DEXPERIENCE,SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systemes, a French “societe europeenne” (Versailles Commercial Register # B 장동성인오락실 야방 322 306 440), or its 특이한여자야상 subsidiaries in the United States and/or other 여자야상쇼핑몰 countries.

View source 장동성인오락실 야동나라 version on businesswire.com:Korea Newswire 장동성인오락실 BTKU distributes your news across 장동성인오락실 서울놀러갈만한곳 every media channels 마이패프닝 through the industry’s largest press release distribution network